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Abstract
Purpose: The primary purpose of this dissertation was to examine the relationship 
between age and receipt of three components of pre-end stage renal disease care prior to 
first initiation of hemodialysis, and to explore the implications of differences in 
interpretation of funding policies for dialysis services in Puerto Rico and the U.S. 
mainland.
Background: The growing burden of chronic kidney disease (CKD) is a national public 
health concern, particularly within the aged population. It is estimated that more than 25 
million Americans are living with some level of kidney disease, with an increasing 
prevalence noted with increasing age (Coresh et al., 2007). Although the Center for 
Medicare and Medicaid Services (CMS) is the primary payer for CKD and ESRD 
services, differences in reimbursement policy interpretation between the U.S. mainland 
and Puerto Rico result in additional burdens for those served. Pre-end stage renal disease 
(ESRD) clinical care can improve outcomes for maintenance hemodialysis patients 
particularly within the elder population.
Methods: Data on the extent of pre-ESRD care by age were derived from the U.S. Renal 
Disease Data System for all patients started on dialysis from 2005 to 2010. Study 
variables included: (a) receipt of nephrology care 12 months prior to starting dialysis, (b) 
receipt of dietitian care at any time prior to starting dialysis, and (c) use of AVF at first 
dialysis. Data for the policy analysis was derived from CMS documents and interviews 
with stakeholders and regulatory agencies.
Results: Less than 2% of MHD patients received all three pre-ESRD care elements, and 
63.3% received none of the three elements of care. The mean number of pre-ESRD care 
elements received by the oldest group (>80 years) did not differ from the youngest group 
(<55 years), but was less than the 55-66 and 67-79 years groups. The policy analysis 
revealed regional variations in the interpretation of the coordination of ESRD benefits 
between the Territory of Puerto Rico and the national health system.
Implications: Major efforts are needed to ensure comprehensive pre-ESRD care for all 
patients with chronic kidney disease as well as a harmonizing of ESRD coordination of 
benefits for dialysis patients.
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Chapter 1 
Dissertation Introduction
The growing burden of chronic kidney disease (CKD) is a national public health
concern, particularly within the aged population. It is estimated that more than 25 million
Americans are living with some level of kidney disease, with an increasing prevalence
noted with increasing age (Coresh et al., 2007). Two key factors contributing to the
increasing national prevalence of CKD are an aging population and the increasing
prevalence of the leading CKD risk factors, diabetes and hypertension (Erdem, Prada, &
Haffer, 2013). People aged >65 years comprise the fastest growing segment of the kidney
failure population (Drawz, Babineau, & Rahman, 2012; United States Renal Data System
[USRDS], 2013a). Both diabetes- and hypertension-related kidney diseases are more
common with increasing age (Yan et al., 2013). Diabetes now accounts for an estimated
45% of new cases of kidney failure and hypertension for an additional 30% (USRDS,
2013b). The implication of increased numbers of older persons and increased rates of
CKD risk factors is a greater number of persons developing end-stage renal disease
(ESRD), thereby creating a substantial burden for the national health care system. Renal
replacement therapy with dialysis or kidney transplantation is a life-saving intervention,




are at high risk for hospitalization or death, which is dependent in part on the quality of 
pre-ESRD care. Understanding the quality of pre-ESRD care for the elderly is a Centers 
for Medicaid and Medicare Services (CMS) priority (St. Peter, Khan, Ebben, Pereira, & 
Collins, 2004).
Early detection and effective treatment are critical to slowing CKD progression to 
ESRD. Many studies have found early nephrology care to be associated with slowed 
progression of ESRD and improved quality outcomes (Echouffo-Techeugui & Kengne; 
2012; Fayer, Nascimento, & Abdulkader, 2011). Once renal replacement therapy is 
imminent, receipt of three elements of care related to quality indicators established by the 
Centers for Medicare and Medicaid Services (CMS) results in reduced morbidity and 
mortality and improved quality outcomes for patients starting dialysis. These elements of 
pre-ESRD care include management of nephrology and dietary kidney care, as well as 
early placement of an arteriovenous fistula (AVF).
Purpose Statement and Hypothesis
This dissertation occurred in three parts: two studies and a related policy analysis.
The purposes of the two studies were to examine age-related differences in the receipt of 
the following quality patient care indicators at the initiation of incident hemodialysis: (a) 
early nephrology management; (b) dietary consultation, and (c) the placement of an 
ateriovenous fistula (AVF). The first study was used as a pilot study in which the 
investigator learned to mine data contained in the U. S. Renal Data System (USRDS) and 
was focused on the relationship between age and placement of an AVF, prior to initiation 
of dialysis. The second study examined the relationships between age and other selected 
patient characteristics and receipt of all three quality care indicators.
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The author hypothesized that persons aged >67 years receive a lower level of quality 
of care than younger persons based on receipt of the quality patient care indicators 
identified. To control for Medicare insurance eligibility at age 65 years the author chose 
age 67 (so a person could get signed up and have Medicare related access to care for at 
least a year) and then engaged in further stratification of ESRD patients into those less 
than 55 years of age, 55-66 years, 67-69 years, and over 80 years.
The purpose of the policy analysis was to gain a clearer understanding of the 
implications of differences in the interpretation and implementation of the Coordination 
Period policy in Puerto Rico for individual patients and health care delivery systems. 
Research Questions
The first study addressed the first of the research questions posed below. The second 
study addressed questions one through three, and the policy analysis addressed question 
four.
1. Is there a difference in rate of placement of an AVF prior to initiation of 
hemodialysis between persons aged >_67 years and those <67 years?
2. Is there a difference in the rate of receipt of early nephrology care prior to 
initiation of hemodialysis between persons aged >67 years and those <67 years?
3. Is there a difference in the rate of receipt of dietary care prior to initiation 
hemodialysis between persons aged >67 years and those <67 years?
4. Is there a difference in the interpretation and implementation of the Coordination 
Period policy in Puerto Rico?
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Methods
The first two studies were retrospective correlational comparative descriptive studies. 
According to Polit and Beck (2012, p 224), “ retrospective studies are best utilized when 
applied when a phenomenon existing in the present is linked to the phenomena that 
occurred in the past.” Such designs specifically address phenomena in which the 
dependent variables’ (quality care indicators) relationship to the independent variable 
(age) has already occurred. For this study, all data were retrospective. The United States 
Renal Disease System (USRDS) was used to extract pre-collected data over a five-year 
period, 2005 through 2010. The studies examined aged-related differences in the receipt 
of the following three elements of pre-ESRD care: (a) receipt of care by a nephrologist at 
least 12 months prior to starting dialysis, (b) receipt of care by a dietician at any time 
prior to starting dialysis, and (c) whether a patient used an AFV at the first outpatient 
dialysis session.
The policy analysis was conducted over an 8-month period. We conducted a search of 
Centers for Medicaid & Medicare Services (CMS) regulatory documents and interviewed 
stakeholders including healthcare professionals, patients, Puerto Rico healthcare 
agencies, and CMS personnel from the New York regional office. Greater details on the 
study methods are provided in the manuscripts included in Chapters 2 ,3 , and 4 
respectively.
Integration of the Three Papers
The dissertation results were reported in three manuscripts. The first manuscript, 
Relationship between Age and Timely Placement o f  Vascular Access in Incident Patients 
on Hemodialysis, examined the use of an arteriovenous fistula (AVF) at the first
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outpatient hemodialysis treatment among U.S. incident patients on hemodialysis. The 
second manuscript, entitled Relationship between Age and Pre-End Stage Renal Disease 
Care in Hemodialysis Patients addressed age-related variations in the receipt of the 
composite of recommended care, including nephrologist and dietician care and use of 
AVF at first outpatient hemodialysis; and the third manuscript, Regional Variations in the 
Interpretation o f the ESRD 30-Month Coordination Period, reviewed the 30-month 
ESRD Coordination Period policy in the Territory of Puerto Rico over an 8-month 
period. The policy analysis revealed regional variations in the interpretation of the 
coordination of ESRD benefits between the Territory of Puerto Rico and the U.S. 
regulatory guidelines. The three manuscripts together indicate that major efforts are 
needed to ensure comprehensive pre-ESRD care for patients of all ages with chronic 
kidney disease as well as a harmonizing of ESRD coordination of benefits for dialysis 
patients. The three manuscripts are included in Chapters 2, 3, and 4, respectively.
Summary
The role of the nephrology nurse in the continuum of care for both the CKD and 
ESRD patient provides a number of expanded opportunities to assist in policy 
development and improved quality of care for this population. The research findings and 
policy analysis may help to fill gaps in the literature on age-related factors associated 
with quality care indicators for patients with ESRD and define future areas of research 
that would improve the care for all patients requiring advanced chronic disease care. In 
addition, the studies highlight the need for further exploration of specific interventions at 
provider and patient/family levels that may increase access to timely quality care for
patients with advanced CKD and the development of a nurse practitioner specialty such 
as a nephrology nurse practitioner. The confluence of these findings can lead to national 
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Abstract
Background and purpose: Placement of an arteriovenous fistula (AVF) prior to 
initiating dialysis can affect clinical outcomes for patients who subsequently initiate 
chronic hemodialysis treatments. Age-related variation in receipt of a functioning AVF 
prior to initiating dialysis is not well known. The purpose of this study was to examine 
age-related rates in use of AVF at the first outpatient dialysis treatment among U.S. 
incident patients on hemodialysis.
Findings: Among 526,145 identified, the use of AVF at the first outpatient dialysis 
treatment was lower in the youngest (<55 year) and oldest (>80 year) vs. both 55-66 year 
and 67-79 year age groups. These findings persisted after adjusting for demographics, 
lifestyle behavior, employment and insurance status, physical/functional conditions, and 
comorbid conditions.
Conclusions: The presence of a functioning AVF at initial dialysis treatment varies by 
age. Modifying healthcare policy and/or expanding the role of the renal nurse practitioner 
should be considered to address this issue.
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Introduction
Chronic kidney disease (CKD) is a significant public health problem affecting 
over 20 million people in the United States (Centers for Disease Control and Prevention 
[CDC], 2012; Rettig, Norris, & Nissenson, 2008). Based on the global contribution of 
CKD to premature mortality and morbidity, the World Health Organization (WHO) 
added CKD to its action plan for the prevention and control o f noncommunicable 
diseases (WHO, 2010). Early detection and early nephrology care influence a multitude 
of public health consequences associated with psychosocial burdens and cost for patients 
with advanced CKD. Access to quality care for patients with advancing CKD may vary 
by race/ethnicity and geographic location (Yan, Cheung, et al., 2013). As such, 
arteriovenous fistula (AVF) placement prior to dialysis is an important indicator of pre- 
ESRD care and a Centers of Medicare and Medicaid (CMS) clinical performance 
measure (CPM) (Arbor Research Collaborative for Health & University of Michigan 
Kidney Epidemiology and Cost Center, 2013). Other performance measures monitored 
by CMS include the early management and surveillance of: (a) anemia, (b) mineral and 
bone disease, (c) infection control, and (d) kidney transplant list and waiting time, all of 
which contribute to the overall quality of care for patients with progressive CKD 
approaching the need for renal replacement therapy (RRT) (CMS, 2007).
The American Nephrology Nurses' Association (ANNA, 2013) has taken the 
position that all patients requiring maintenance hemodialysis therapy should have a 
functioning permanent vascular access in place before initiating hemodialysis and that 
access placement be established in stage 4 of CKD. AVF is strongly associated with 
lower rates of infection and mortality (Wish; 2010). One of every two patients starting
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hemodialysis is over 65 years of age (United States Renal Data System [USRDS] 2013) 
and many factors that influence AVF success such as comorbidities, smaller vessel size, 
and atherosclerotic disease are more prevalent in older patients and could influence the 
successful and timely placement of an AVF.
Two key factors contributing to the increasing prevalence of CKD are an aging 
population and the increasing prevalence of the leading CKD risk factors, diabetes and 
hypertension (Erdem, Prada, & Haffer, 2013). People over 65 years of age comprise the 
fastest growing segment of the kidney failure population (Drawz, Babineau, & Rahman, 
2012; USRDS, 2013). Both diabetes and hypertension are more common with increasing 
age (Yan, Norris, et al., 2013). Diabetes now accounts for an estimated 45% of new cases 
of kidney failure and hypertension for an additional 30% (USRDS, 2013). The 
implications of aging and ESRD for the national healthcare system are substantial and 
understanding the quality of pre-ESRD care for the elderly is a CMS priority.
This study was conducted to assess potential age-related differences in AVF 
placement. We hypothesized that older patients were less likely to have a functioning 
AVF in place at the first dialysis treatment. To test this, we performed a national 
population analysis to assess age-related differences in the use o f AVF at the first dialysis 
treatment.
Methods 
Data Sources and Study Population
The study included all new maintenance dialysis patients treated with renal 
replacement therapy living in any of the 50 states or the District o f Columbia who were 
18 years of age or older at the time of initiation of dialysis and entered in the United
States Renal Data System (USRDS) between 2005 and 2010. USRDS is a national 
population-based registry that includes almost all U.S. patients with kidney failure. In 
2005, the CMS ESRD Medical Evidence (ME) Report was revised to include information 
on pre-renal failure care received during the year prior to initiation of renal replacement 
therapy, so data collection included all patients who completed the revised ME form. 
Study Variables
Data extracted from the USRDS included whether a patient used an AVF at the 
first outpatient hemodialysis session. Additional data was extracted to assess whether or 
not patients had received care by a nephrologist at least 12 months prior to starting 
dialysis, and whether or not patients had received care by a dietitian at any time prior to 
starting dialysis. Data on patient variables such as demographic characteristics, 
employment status, health insurance coverage, and comorbid conditions were also 
obtained from the USRDS. Data included gender, race and ethnicity, age at dialysis 
onset, lifestyle behavior (current smoking), health care access, health insurance status at 
the initiation of dialysis, physical/functional conditions, and various comorbid conditions 
(e.g., diabetes, hypertension, cardiovascular diseases, and cancer). Employment status at 
six months prior to ESRD was used as a proxy measure of access to health care. Each 
patient’s health insurance status was assigned to one of four categories: no insurance, 
Medicaid only, Medicare only, and other including employer-group only and/or two or 
more carriers. The study was approved by the Institutional Review Board (IRB) for 
Health Sciences Research at University of Virginia.
Statistical Analysis
We assessed the differences in use of an AVF at the first outpatient dialysis 
session by comparing percentages of patients on hemodialysis with AVF across four age 
categories (<55 years, 55-66 years, 67-79 years, >80 years of age). We examined the 
unadjusted odds ratios with logistic regression and then the odds ratios adjusted for 
patient characteristics, including demographics, lifestyle behavior, employment status 
and insurance, physical/functional conditions, and various comorbid conditions as listed 
in Table 1. The purpose of adjusted analysis was to assess whether the age related 
differences in use of an AVF at the first outpatient dialysis session persisted after 
accounting for the patient factors considered. To compare these four age groups, we 
present results of six pairwise comparisons by the order of age group: age groups of 55- 
66 years, 67-79 years, and > 80 years compared with the youngest age group (<55 years). 
Then age groups of 67-79 years and > 80 years compared with the second youngest age 
group (55-66 years), and finally the age group of > 80 years compared with the third 
youngest group (67-79 years).
Results
Patient Characteristics
Patient characteristics are presented in Table 1. Of the 559,056 patients reviewed, 
153,611 (27.5%) were <55 years of age, 154,126 (27.6%) were 55-66 years of age, 
168,044 (30.0%) were 67-79 years of age, and 83,275 (14.9%) were >80 years of age. 
Compared to older patients, those <55 years of age were more likely to be male, of a 
racial/ethnic minority, uninsured, less likely to be employed at 6 months before ESRD, 
and less likely to have most comorbid medical conditions.
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Regression Analyses
Our logistic regression for AVF was restricted to the subset of incident patients on 
hemodialysis at the ESRD onset (N= 526,145). Unadjusted logistic regression analyses 
were first performed comparing the likelihood of using an AVF at first dialysis (Table 2) 
among the four age groups. Six pair-wise comparisons were made: 55-66 years, 67-79 
years, and >80 years against the reference group (<55 years); 67-79 years, and >80 years 
compared to the 55-66 year-old group; and >80 years compared to the 67-79 year-old 
group. The likelihood of using an AVF at first dialysis was lower in the youngest and 
oldest groups (<55 years and >80 years) compared to the 55-66 and 67-79 year-old 
groups. The likelihood of using an AVF at first dialysis was similar in 55-66 and 67-79 
year-old groups. Likelihood was also comparable between the <55 years and >80 years 
age groups. After adjusting for multiple patient characteristics, including demographics, 
lifestyle behavior, employment and insurance status, physical/ functional conditions, and 
comorbid conditions listed in Table 1, the likelihood of using an AVF at first dialysis 
remained lower for the youngest and oldest groups (<55 years and >80 years) in 
comparison to the 55-66 and 67-79 year-old groups (Table 3). Sensitivity analyses 
revealed similar patterns between age and receipt of pre-ESRD nephrology care (N= 
491,992) as well as age and receipt of pre-ESRD dietician care (N= 450,626) (data not 
presented).
Discussion
This is the first study to our knowledge that examined age-related differences in 
the use of an arteriovenous fistula at the initial hemodialysis treatment. Two specific 
groups were identified as having the lowest rate of AVF use at their first hemodialysis
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treatment, those <55 years of age and those > 80 years of age. Our findings are consistent 
with those of Lilly et al. who reported lower odds of AVF placement among 195,756 
adult incident hemodialysis patients older than 85 years of age (but not younger patients) 
as well as for women, blacks, Hispanics, and persons with diabetes, peripheral vascular 
disease, congestive heart failure, other cardiac disease, and underweight (Lilly et al., 
2012). In contrast to our analysis, they examined patients with 6 months or more of prior 
nephrology care which may have pre-selected younger patients with insurance and may 
explain why they only found the lower AVF rates among older patients.
A similar analysis by Patibandla et al. found increasing age, female sex, black 
race, lower body mass index, urban location, certain comorbidities, and shorter pre-end- 
stage renal disease nephrology care were associated with a significantly lower likelihood 
of AVF being placed, even if  it was not ready for use at the first dialysis treatment, 
among 118,767 incident hemodialysis patients >67 years of age (Patibandla et al., 2013). 
This study differed slightly from ours in that Patibandla et al. specifically looked at AVF 
being placed prior to dialysis, in contrast to AVF being used at first dialysis as examined 
in our analysis.
Study limitations include the cross sectional nature of the data that only allows us 
to assess relationships and not causal effects. In addition, a prior report of disagreement 
between information from the CMS Medical Evidence Report and Medicare physician 
claims for pre-ESRD care suggests the validity of CMS Medical Evidence Report is not 
clear (Kim, Desai, Chertow, & Winkelmayer, 2012). We examined pre-ESRD nephology 
and dietician care and found results similar to use of an AVF at initial dialysis, 
recognizing that timing of pre-ESRD care is inherently less definitive than use of an AVF
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at dialysis. Finally, not all patients may be good candidates for an AVF (Gomes, Schmidt, 
& Wish, 2013), but that should not prevent the renal community from striving to meet 
Healthy People 2020 goals for pre-ESRD care (USRDS, 2013).
The recommendations from our study include the need for promoting more 
universal insurance coverage such as expanded Medicaid and similar coverage for 
uninsured as should be provided with the new Affordable Care Act (Health Resources 
and Services Administration, 2011). In addition, prospective studies are needed to 
examine specific interventions at provider and patient/family levels that may increase 
access to timely quality care for patients with advanced CKD.
Implications for Nephrology Nurses
These findings should be a reminder to nephrology nurses, as members of the pre- 
ESRD and ESRD patient care team and, in some cases, primary care providers, to not 
only maintain diligence in facilitating quality pre-ESRD care but to be cognizant of the 
additional risks that exist for younger (<55 years) and older (>80 years) patients related to 
obtaining an AVF for use at the first dialysis treatment. Working closely with social 
workers and family to address key socio-demographic issues may be important for 
engaging and motivating many patients. Strategies to enhance care coordination between 
primary care providers and the CKD/ESRD team should be explored by the all members 
of the health care team, including nurses and nurse practitioners. There is growing 
recognition and acceptance across multidisciplinary programs that nurse practitioners can 
make a positive contribution to healthy outcomes through an expanded role in working 
with public health agencies, community-based organizations (CBOs), and in-patient 
units. Polkinghome et al. reported an increase in AVF placement from less than 50% to
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65% following the introduction of a multifaceted intervention that included a vascular 
access nurse coordinator and an algorithm to prioritize surgery (Polkinghome, 
Seneviratne, & Kerr, 2009). The present findings of both low rates of AVF use at the first 
dialysis treatment and disparities of AVF use across age groups should prompt a call to 
action by ANNA for nurses to more aggressively pursue a substantive leadership role on 
the CKD/ESRD team. Initiatives may include the use of nurse practitioners and/or 
clinical nurse specialists in CKD clinics as suggested by Davis and Zuber (2013). A joint 
initiative between ANNA and the American Society of Nephrology and/or Renal 
Physicians Association may help to address the issue o f ensuring the highest quality of 
care for patients with advanced CKD.
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Table 1. Patient Characteristics by Age Group
Patient characteristic
Age group






> 80 years 
(n=83,275)
Age (years), Mean ±SD 43.4±8.9 60.7±3.4 72.9±3.7 84.1±3.4
Male sex (%) 59.2 56.0 54.5 54.2
Race/ethnicity (%)
Non-Hispanic white 37.3 50.0 61.9 72.8
Non-Hispanic black 40.0 30.5 22.6 15.7
Hispanic 16.9 14.1 10.6 7.1
Other 5.8 5.4 4.9 4.3
Employed at 6 months before end- 
stage renal disease (%)
66.3 79.4 91.3 93.7
Insurance coverage (%)
No insurance 18.3 8.4 1.0 0.6
Medicaid only 23.7 14.5 2.4 1.4
Medicare only 5.9 12.9 22.1 21.4
Other/combination 52.0 64.2 74.5 76.7
Current smoker (%) 9.8 7.8 4.4 1.6
Physical/ functional conditions
Inability to ambulate (%) 3.4 6.6 8.7 11.1
Inability to transfer (%) 1.5 3.0 4.5 6.0
Needs assistance with daily 
activities (%)
6.1 10.2 14.1 19.0
Institutionalized - Nursing 
Home (%)
2.6 5.6 9.1 13.7
Comorbid conditions
Hypertension (%) 83.7 85.2 85.0 84.5
Diabetes (%) 46.9 63.7 56.8 39.9
Congestive heart failure (%) 19.2 32.4 39.7 45.7
Arteriosclerotic heart disease 
(%)
8.5 20.6 28.6 31.9
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Other heart diseases (%) 8.4 15.5 21.3 25.3
Cerebrovascular accident/ 
transient ischemic attack (%)
5.3 10.1 12.1 12.0
Peripheral vascular disease (%) 7.4 14.4 17.9 17.2
Amputation (%) 3.3 4.2 2.8 1.4
Chronic obstruction pulmonary 
disease (%)
3.7 9.2 12.9 12.4
Cancer (%) 2.7 6.6 10.6 12.1
Outcome8
AVF at first dialysis (%) 12.4 14.6 14.7 12.3
Receipt of nephrologist care at 
least 12 months before ESRD 
(%)
22.7 27.1 29.6 28.0
Receipt of dietitian care at any 
time before ESRD (%)
10.3 11.8 11.6 10.6
* Sample size varied: N= 526,145 for AVF, N= 491,992 for nephrologist care, and N= 450,626 
for dietitian care.
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Table 2. Unadjusted Odds Ratios of Having an Arteriovenous Fistula at First 
Hemodialysis
Age Group Odds ratio 95% Cl P value
55-66 vs. <55 years 1.21 (1.18-1.23) 0.000
67-79 vs. <55 years 1.22 (1.19-1.24) 0.000
>80 vs. <55 years 0.99 (0.96-1.01) 0.313
67-79 vs. 55-66 years 1.01 (0.99-1.03) 0.354
>80 vs. 55-66 years 0.82 (0.80-0.84) 0.000
>80 vs. 67-79 years 0.81 (0.79-0.83) 0.000
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Table 3. Adjusted Odds Ratios of Having an Arteriovenous Fistula at First 
Hemodialysis
Age Group Odds ratio8 95% C l P value
55-66 vs. <55 years 1.18 (1.15-1.21) 0.000
67-79 vs. <55 years 1.16 (1.14-1.19) 0.000
>80 vs. <55 years 0.98 (0.95-1.01) 0.173
67-79 vs. 55-66 years 0.99 (0.97-1.01) 0.208
>80 vs. 55-66 years 0.83 (0.81-0.85) 0.000
>80 vs. 67-79 years 0.84 (0.82-0.86) 0.000
8 Adjusted for the patient characteristics listed in Table!.
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Abstract
Background and objectives: Receipt of pre-end-stage renal disease (ESRD) clinical care 
can improve outcomes for maintenance hemodialysis (MHD) patients. The study 
addressed age-related variations in receipt of a composite o f recommended care to 
include nephrologist and dietician care and use of arterio-venous fistula at first outpatient 
hemodialysis.
Findings: Less than 2% of MHD patients received all three forms of pre-ESRD care, and 
63.3% received none of the three elements of care. The mean number of pre-ESRD care 
elements received by the oldest group (>80 years) did not differ from the youngest group 
(< 55 years), but was less than the 55-66 and 67-79 years groups; adjusted ratios of 0.93 
(0.92-0.94; p <0.001) and 0.94 (0.92-0.95; p < 0.001), respectively.
Conclusions: A major effort is needed to ensure comprehensive pre-ESRD care for all 
patients with advanced CKD, especially for the youngest and oldest patient groups, who 
were less likely to receive recommended pre-ESRD care.
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Introduction
Chronic kidney disease (CKD) is a major public health problem affecting one in 
eight adults (Levey, Andreoli, DuBose, Provenzano, & Collins, 2007) and leading to end- 
stage renal disease (ESRD) requiring treatment with renal transplantation or dialysis 
(Stevens & Levin, 2013) or premature mortality (Go, Chertow, Fan, McCulloch, & Hsu, 
2004). The psychosocial and economic burden of ESRD has challenged the nephrology 
community to promote early detection and intervention to improve outcomes for patients 
with CKD ( Rettig, Vargas, Norris, & Nissenson, 2010; Rettig, Norris, & Nissenson, 
2008).
For patients with advanced CKD, early referral for specialty care may slow the 
decline in renal function (Chen et al., 2008; Jones, Roderick, Harris, & Rogerson, 2006) 
and reduce subsequent mortality (Jones, Roderick, Harris, & Rogerson, 2006). It is also 
associated with reduced progression to ESRD and improved quality of life and clinical 
outcomes after the initiation of dialysis (Brick & Ellis, 2009; Lee et al., 2014; Smart, 
Dieberg, Ladhani, & Titus, 2014). In addition to improving patient outcomes, timely pre- 
ESRD care can reduce health care costs for those needing replacement renal therapy 
(Ismail, Neyra, & Hakim, 1998; Stroupe et al., 2011). Because of these reports, clinical 
practice guidelines now recommend that all patients in advanced stages (stage 4 and 5) of 
CKD receive nephrology care (Levey, Atkins, et al., 2007; Stevens & Levin, 2013). 
Unfortunately, as many as 30-50% of patients undergoing maintenance dialysis in the 
United States do not receive adequate pre-ESRD care before starting dialysis (United 
States Renal Data System [USRDS] 2013).
The issue of quality care for patients with advanced CKD is an important concern
for the nephrology nursing community (American Nephrology Nurses' Association 
[ANNA], 2013; Harford, Clark, Norris & Yan, in press) and the American Nephrology 
Nurses' Association has taken the position that all patients requiring maintenance 
hemodialysis therapy should have quality pre-ESRD care prior to initiating hemodialysis 
(ANNA, 2013). The nursing paradigm of four interrelated concepts of person, health, 
environment, and nursing described by McEwen and Wills (2007) provides an ideal 
conceptual framework for pre- ESRD education. This is particularly important since 
nurses are frequently key members of the pre-ESRD education team, and holistic, patient- 
centered care and education may assist the individual with advanced CKD to receive the 
necessary pre-ESRD care and achieve optimal health (Key, 2008).
Two key factors contributing to the increasing prevalence of CKD are an aging 
population and the increasing prevalence of diabetes and hypertension, the leading CKD 
risk factors (Erdem, Prada, & HafFer, 2013). While ESRD affects persons of all ages, it is 
more common with advancing age, with one of every two patients starting hemodialysis 
over 65 years of age. People in this age group comprise the fastest growing segment of 
the kidney failure population (Drawz, Babineau, & Rahman, 2012; USRDS, 2013), and 
those over 80 years of age are at even higher risk for ESRD (USRDS 2013).
Diabetes now accounts for an estimated 45% of new cases of kidney failure and 
hypertension for an additional 30% (USRDS, 2013). These conditions are even more 
common among ESRD patients with increasing age (Yan et al., 2013). Age has been 
associated with differences in the presence of a functioning arteriovenous fistula (AVF) 
at initial dialysis treatment, suggesting age may affect receipt of pre-ESRD care (Harford, 
Clark, Norris, & Yan, in press). For example, an analysis of the Department of Veterans
Affairs (VA) and Medicare healthcare systems found that one-third of older veterans 
initiating dialysis did not receive pre-ESRD nephrology care (Fischer et al., 2010). The 
implications of aging and ESRD for the national healthcare system are substantial and 
understanding the quality of pre-ESRD and ESRD care for the elderly are Centers for 
Medicare and Medicaid Services (CMS) priorities.
To better determine if age influences the quality of pre-ESRD care, we conducted 
a national population analysis to assess potential age-related differences in the composite 
of three pre-ESRD care elements that are part of the CMS clinical performance metrics: 
(a) receipt of nephrology care at least 12 months prior to the initiation of dialysis, (b) 
dietitian care prior to the initiation of dialysis, and (c) the use o f AVF for the first dialysis 
treatment in maintenance hemodialysis patients (MHD). We hypothesized that older 
patients were less likely to have received the composite of CMS recommended pre-ESRD 
care elements than their younger counterparts.
Methods 
Data Sources and Study Population
The study included all new MHD patients treated with renal replacement therapy 
living in any of the 50 states or the District of Columbia who were 18 years of age or 
older at the time of initiation of dialysis and entered in the United States Renal Data 
System (USRDS) between 2005 and 2010. USRDS is a national population-based 
registry that includes almost all U.S. patients with kidney failure. In 2005, the CMS 
ESRD Medical Evidence (ME) Report was revised to include information on pre-ESRD 
care that patients had received during the year prior to initiation of renal replacement 
therapy. Data collection included all patients who completed the revised ME form.
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Study Variables
Data extracted from the USRDS included the three elements of recommended 
pre-ESRD care: (a) receipt of care by a nephrologist at least 12 months prior to starting 
dialysis, (b) receipt of care by a dietitian at any time prior to starting dialysis, and (c) 
whether a patient used an AVF at the first outpatient dialysis session. Data extracted also 
included gender, race and ethnicity, age at dialysis onset, lifestyle behavior (current 
smoking), health care access, health insurance status at the initiation of dialysis, 
physical/functional conditions, and various comorbid conditions (e.g., diabetes, 
hypertension, cardiovascular diseases, and cancer). Employment status at six months 
prior to ESRD was used as a proxy measure of access to health care. Each patient’s 
health insurance status was assigned to one of four categories: no insurance, Medicaid 
only, Medicare only, and other, including employer-group only and/or two or more 
carriers. The study was approved by the Institutional Review Board (IRB) at University 
of Virginia and the IRB at the University of San Diego.
Statistical analysis
The outcome was the composite of the three pre-ESRD care elements for MHD 
patients, measured as the total number of care elements received per patient (range: 0-3). 
We used Poisson regression, which is appropriate for frequency data, to compare four age 
categories (< 55 years, 55-66 years, 67-79 years, >80 years of age), expressed as ratios of 
the mean number of care elements received by respective age groups compared to that in 
the reference group. The ratios were adjusted for patient characteristics, including 
demographics, lifestyle behavior, employment status and insurance, physical/functional 
conditions, and various comorbid conditions listed in Table 1. The purpose of adjusted
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analysis was to assess whether any age-related differences in the composite of three pre- 
ESRD care elements received persisted after accounting for the patient factors 
considered. To compare these four age groups, we present results of pairwise 
comparisons by the order of age group: age groups of 55-66 years, 67-79 years, and > 80 
years compared with the youngest age group (<55 years). Then age groups of 67-79 years 
and > 80 years were compared with the second youngest age group (55-66 years), and 
finally the age group of > 80 years compared with the third youngest group (67-79 years).
Results
As indicated in Table 1,15.1% of the 412,291 patients were over 80 years of age, with 
the rest relatively evenly distributed among the three other age groups. Compared to older 
patients, those <55 years of age were more likely to be male, of a racial/ethnic minority 
group, and uninsured, less likely to be employed at 6 months before ESRD, and less 
likely to have most comorbid medical conditions. In contrast, those >80 years were more 
likely to be non-Hispanic white, have insurance, have been employed, and have 
functional disabilities than other age groups.
Table 2 presents findings related to receipt of pre-ESRD care elements for the 
total sample as well as for specific age groups. Nearly two-thirds of patients (63.3%) did 
not receive any of the three care elements considered, 25% received one care element, 
and roughly 10% received two care elements. Less than 2% received all three elements of 
recommended pre-ESRD care. Overall, the average number of care elements received by 
patients in the entire cohort was 0.50. Among patients less than 55 years of age, the mean 
was 0.43, increasing to 0.52 for those in 55-66 year age group and 0.55 for those 67-79 
years of age and then declining to 0.51 for the oldest group.
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Regression Analyses
Both unadjusted and adjusted Poisson regression analyses were performed comparing the 
mean number of pre-ESRD care elements received (nephrologist care, dietitian care,
AVF used at initial dialysis) between the age groups (Table 3). In unadjusted analyses, 
the older cohorts, including those over 80 years of age were significantly more likely to 
have received the recommended composite care than the youngest age group (<55 years). 
However, those over 80 years received less care than either the 55- to 66-year-olds (ratio 
- 0.97 [0.96-0.99]) or the 67- to 79-year-olds (ratio - 0.92 [0.91-0.93]).
After adjusting for multiple demographic, clinical, and pre-ESRD health-care 
access factors, there were no longer significant differences in the number of 
recommended care elements received by the oldest (>80 years) and youngest (<55 years) 
groups. However the oldest (>80 years) group still received significantly less care than 
the 55- to 66-year-old group (ratio - 0.93 [0.92-0.94]) and the 67- to 79-year-old group 
(ratio - 0.94 [0.92-0.95]) (See Table 3).
Discussion
This is the first study to our knowledge that examined at the national level age- 
related differences in the receipt of the composite of pre-ESRD nephrology and dietitian 
care as well as the use of AVF at the first dialysis treatment. After multiple statistical 
adjustments for patient level factors, receipt of the recommended elements of pre-ESRD 
care was lower in the youngest and oldest groups (<55 years and >80 years) in 
comparison to 55-66 and 67-79 year old groups. In addition we noted that pre-ESRD care 
was extremely low with less than 2% of the MHD population reported to have received 
all three forms of recommended care.
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Our findings o f lower receipt of composite pre-ESRD care are consistent with 
those of Lilly et al. (2012), who reported lower odds of AVF placement among 195,756 
adult incident MHD patients over 85 years of age. The current study builds upon our 
prior report of lower odds of AVF placement among MHD patients >80 years of age by 
expanding to assess the composite of pre-ESRD care elements (Harford et al., in press). 
Our findings were surprising as we hypothesized that the older patients would receive 
lower levels of composite pre-ESRD care. We expected younger patients to have lower 
unadjusted rates of pre-ESRD care due to less insurance coverage (USRDS, 2013), but 
after adjusting for this and other patient-level factors, we anticipated they would no 
longer have lower levels of pre-ESRD care. Our primary hypothesis was that the oldest 
patients would receive lower levels of composite pre-ESRD care based on prior evidence 
of lesser delivery of health care for the aging population after adjusting for insurance 
coverage. Interestingly, we found it was both the oldest and youngest groups that 
received lower levels of composite pre-ESRD care after adjusting for patient factors.
It is known that nephrologist care prior to ESRD results in improved clinical 
outcomes. Under a nephrologist’s care, patients are more likely to receive care from a 
renal care team and receive other important pre-ESRD care services, including dietitian 
referral, timely placement of AVF, and enhanced management of multiple co-morbid 
conditions (Fayer, Nascimento, & Abdulkader, 2011; Prakash et al., 2010). In this study, 
we examined how the rates of receiving these important care indicators varied among 
different age groups of ESRD patients.
The elderly constitute a substantial and growing portion of the ESRD population, 
and rates of treated ESRD among the older elderly (>80 years) have risen by more than
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50% in the last decade (Tamura, 2009) Quality of life results are mixed with older ESRD 
patients reporting similar levels of mental well being but reduced physical well-being in 
comparison to their younger ESRD peers (Tamura, 2009). One of the first dilemmas 
encountered in the management of elderly patients approaching ESRD is deciding 
whether to initiate renal replacement therapy (Vachharajani et al., 2014). Once a decision 
has been made to initiate renal replacement therapy these patients should receive the 
same quality of care as their younger ESRD peers. This can be challenging at times given 
the high prevalence of comorbidities and complex quality of life issues associated with 
the older ESRD population. These factors pose substantial challenges for clinicians, such 
as technical difficulties in the placement of an arteriovenous fistula, that complicate 
clinical decision-making and provision of optimal care, (Vachharajani et al., 2014). By 
examining the composite of pre-ESD care elements, we are better able to examine the 
broader risk for suboptimal care for the elderly. This approach provides an expansive 
view not limited to technical vascular issues associated with aging.
Our findings of an extremely low rate of composite pre-ESRD care likely reflects 
a combination of factors from fragmented care for patients with advanced CKD (Rastogi, 
Linden, & Nissenson, 2008), to limited or no insurance for many with advanced CKD 
(Owen & Norris, 1994), and not having a nephrologist and the nephrology team as the 
primary care provider for patients with advanced CKD as they prepare to transition to 
ESRD (Owen & Norris, 1994; Rastogi, Linden, & Nissenson, 2008). Regardless of the 
reason(s), our findings highlight a major gap in pre-ESRD care delivery and underscore 
the need for new models of care to bridge this gap, such as nurse directed care and/or 
health navigators.
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Study limitations include the cross sectional nature of the study design that only 
allows us to assess associations and not causal effects. Not all patients may be good 
candidates for an AVF, especially older elderly (Gomes, Schmidt, & Wish, 2013), but 
that is why we also examined other aspects of pre-ESRD care. Finally, there has been a 
report of disagreement between information from the CMS Medical Evidence Report and 
Medicare physician claims for pre-ESRD care, suggesting the validity of data derived 
from one or both may be questionable (Kim, Desai, Chertow, & Winkelmayer, 2012). 
However, the CMS Medical Evidence Report is the most comprehensive source of pre- 
ESRD care data available at the present time.
Implications for Nephrology Nurses
Clinical (e.g. poor vasculature for AVF placement) and/or psychosocial (fear, 
trust, health beliefs) factors may underlie the less frequent receipt of composite pre- 
ESRD care in younger and old elderly MHD patients. Given that nurses are frequently 
providers of pre-ESRD education, a nurse-led quality improvement initiative grounded in 
person, health, environment, and nursing might help to better engage these two groups of 
high-risk patients, as well as the entire community of pre-ESRD patients (Key, 2008; 
McEwen & Wills, 2007). The nursing approach of assisting the individual with pre- 
ESRD to attain balance through holistic, patient-centered care and education may help to 
ensure that composite pre-ESRD goals are met (Key, 2008).
Quality improvement initiatives in geriatric ESRD care have been successfully 
implemented and may ultimately improve care for elderly patients with ESRD (Tamura, 
2009; Winkelmayer & Tamura, 2012). Our findings of reduced pre-ESRD care should 
help to clarify some of the opportunities for pre-dialysis decision-making and
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management in the older elderly as well as younger MHD patients. Given our results, it is 
imperative that a more consistent approach to the provision of pre-ESRD care needs to be 
taken for this entire population.
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Table 1. Patient Characteristics by Age Group






> 80 years 
(n=62,317)
Age (years), Mean ±SD 43.4±8.9 60.7±3.4 72.9±3.7 84.1±3.4
Male (%) 59.8 56.1 54.6 54.2
Race (%)
Non-Hispanic white 36.8 50.0 62.5 73.7
Non-Hispanic black 40.8 30.9 22.5 15.4
Hispanic 16.8 14.0 10.4 6.9
Other 5.6 5.1 4.6 4.0
Insurance (%)
No insurance 19.2 8.7 1.0 0.5
Medicaid only 24.1 14.5 2.2 1.2
Medicare only 6.0 13.1 22.0 20.9
Other/combination 50.7 63.7 74.8 77.4
Employed (%) 66.7 80.3 92.3 94.6
Hypertension (%) 83.7 85.5 85.6 85.1
Diabetes (%) 47.2 64.0 57.1 39.9
Congestive Heart Failure (%) 20.4 34.1 41.3 47.1
Arteriosclerotic Heart Disease 
(%)
9.2 22.1 30.8 34.3
Other Cardiac Disease (%) 8.7 15.7 21.4 25.5
Cerebrovascular
accident/transient ischemic attack 
(%)
5.5 10.4 12.5 12.6
Peripheral Vascular Disease (%) 8.0 15.3 19.0 18.1
Amputations (%) 3.5 4.4 2.9 1.4
Chronic Obstructive Pulmonary 
Disease (%)
3.9 9.8 13.4 12.7
Current smoker (%) 10.5 8.3 4.6 1.7
Cancer (%) 2.9 7.1 11.2 12.7
Inability to ambulate (%) 3.7 6.8 8.9 11.1
Inability to transfer (%) 1.5 3.1 4.5 5.9
Needs assistance with daily 
activities (%)
6.5 10.7 14.5 19.3
Institutionalized - Nursing Home 
(%)
2.6 5.5 8.8 13.2
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Table 2. Receipt of Pre-ESRD Care Elements, by Age Group













at least 12 
months before 
ESRD (%)
20.2 25.2 28.2 26.9 25.0
Receipt of 
dietitian care at 
any time before 
ESRD (%)
9.8 11.6 11.5 10.6 10.9
AVF at first 
dialysis (%)
12.7 15.2 15.5 13.0 14.3
Mean number of 
the three care 
elements 
received
0.43 0.52 0.55 0.51 0.50




None 68.4 62.4 59.8 62.4 63.3
1 element 21.9 25.3 27.2 26.1 25.0
2 elements 8.3 10.3 11.0 9.9 9.9
All 3 
elements
1.4 2.0 2.0 1.6 1.8
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Table 3. Unadjusted and Adjusted Ratios of the Mean Number of pre-ESRD Care 
Elements Received for Respective Age Groups Compared with that In Reference Group
Age Ratio P value Ratio P value Ratio P value
Group
1 (reference)







< 0.001 1 (reference)
1.18(1.16 
1.20)
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Background and Objectives: Coordination of benefits (COB) between the Centers for 
Medicare & Medicaid Services (CMS) national healthcare system and other healthcare 
insurance systems plays an important role in the determination of cost covered services 
for the end stage renal disease (ESRD) patient.
Methods: The study reviewed the 30-month ESRD Coordination Period policy in the 
Territory of Puerto Rico over an 8-month period. The review included a search of 
regulatory documents and key stakeholder interviews with healthcare professionals, 
patients, and regulatory agencies in the Territory of Puerto Rico and the Centers for 
Medicaid & Medicare Services regional office.
Findings: In the Territory of Puerto Rico, the ERSD coordination policy is three months 
based on a local 90-day ESRD coordination period policy versus the national regulatory 
guidelines of 30 months. The variance interpretation of the ESRD COB has led to 
confusion among the payors, healthcare providers, the Medicare Administrative 
Contractor, and the patient in determining primary and secondary payor status for 
Medicare. This confusion has led, in turn, to delayed payments for health care delivery 
systems and duplication of copayments and out-of-pocket cost burden for patients.
Conclusions: A major effort is needed to harmonize the coordination period policy 
between the Territory of Puerto Rico and the national healthcare system to reduce undue
burdens on providers and patients.
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Introduction
Chronic kidney disease (CKD) is a major source of premature morbidity affecting 
more than 10% of adults in the United States. Over 110,000 people each year develop 
end-stage renal disease (ESRD) requiring renal replacement therapy with either dialysis 
or renal transplantation (Centers for Disease Control and Prevention [CDC], 2014; 
National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2014). In 
1972, to address the growing disease burden, a special provision of the Social Security 
Act declared persons with ESRD who required renal replacement therapy to be disabled 
for purposes of Medicare Parts A and B. Medicare was established just seven years 
earlier in 1965 to support health care for the elderly and subsequently extended to 
disabled persons by Social Security Act amendments (Rettig, 2011). The ESRD Medicare 
program has now been in place for over 40 years.
At the level of the individual patient, the ESRD Medicare Secondary Payer 
provision or ESRD Coordination Period provides for a coordination of benefits period 
between Medicare and private health insurance plans for individuals entitled to Medicare 
solely on the basis of ESRD. If an individual is entitled to Medicare because of ESRD 
and is covered by an Employer Group Health Plan (EGHP), the EGHP is the first payer 
(primary) for the first 30 months (Centers for Medicare and Medicaid Services [CMS], 
2013a). When first enacted in 1981, the period of coverage was 18 months, but was 
extended to 30 months in 1997 by the Balanced Budget Act (CMS, 2002). The regulation 
stipulates the EGHP is primary regardless of the number of employees and/or the 
Medicare beneficiary's employment status. This stipulation applies to all 50 states; the 
District of Columbia; the Commonwealth of Puerto Rico; the Virgin Islands; Guam; the
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Commonwealth of the Northern Mariana Islands; and American Samoa as well as the 
territorial waters adjoining the land areas of the United States for services provided 
onboard a ship (CMS, 2013b). The 30-month ESRD Coordination Period has been 
implemented in every region of the United States except of the territory of Puerto Rico 
(C. Hernandez, personal communication, May, 2014; First Coast Service Options Inc. 
2014a). We undertook the present study to better understand the implications of 
differences in the interpretation and implementation of the Coordination Period policy in 
Puerto Rico.
Methods
We conducted a search of regulatory documents as well as key stakeholder 
interviews regarding the 30-month ESRD Coordination Period in the territory of Puerto 
Rico generated over an 8-month period. A synthesis of findings and implications for the 
way forward are presented here.
Findings
Many dialysis patients in Puerto Rico have other (EGHP) insurance, but the 
insurance covers only the first 90 days of dialysis treatments after the onset of ESRD. For 
such patients, Medicare is the primary payer for dialysis treatments during the standard 
ESRD beneficiary coordination period, which extends from the fourth through the 30th 
month after onset of ESRD rather than after the 30th month. In Puerto Rico, Medicare 
Secondary Payer (MSP) billing does not apply in such situations, as the health care 
insurers in Puerto Rico do not interpret the Medicare Coordination period to begin after 
30 months. Typically, in other areas where the 30* month rule is enforced, Medicare 
becomes the primary payer after the 30th month coordination period. In Puerto Rico,
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however, Medicare is the secondary payer after the third month. The interpretation of 
Medicare’s status as primary payer is believed to be supported by the Medicare 
regulations at 42 CFR §411.161 and §411.162 and by the guidelines at CMS 100-05 
(MSP Manual) Chapter 1 §10.2 and §70.3 and Chapter 3 § 10.2 (CMS, 2009,2012a, 
2012b; National Archives and Records Administration, 2014)). These interpretations 
have set forth the 90-day coordination period practiced in Puerto Rico to differ from the 
30-month coordination period practiced elsewhere. This has important implications for 
dialysis care facilities, nephrologists, and the patients they care for.
The CMS claims system has no procedure to allow for Medicare as the primary 
payer for these beneficiaries who are within the 3rd -30th month ESRD period. Insurance 
companies and healthcare providers use the Common Working File (CWF) to obtain 
Medicare health insurance eligibility information. The CWF informs the claim system if 
the beneficiary is within the coordination period and if the individual has other insurance 
(e.g., EGHP). The aggregate insurance information and patient demographic data assist 
both Medicare and the healthcare provider in determining whether Medicare is the 
primary or secondary payer (CMS, 2013c, 2013d). The CWF does not include a data field 
that would identify the dialysis treatment as not covered by an active insurer and allow a 
Medicare primary payment. From our discussions, it is the position of intermediary 
insurers in Puerto Rico that dialysis treatment could be categorized as not covered by the 
insurer and that Medicare would then become the primary payer. They also voiced the 
perception that CMS has chosen not to invest in a system improvement that would 
directly address this situation.
First Coast Service Options Inc. (FCSO, 2014b), the Medicare Administrative
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Contractor (MAC) for Puerto Rico, uses a work-around in order to pay the claims for 
these beneficiaries. The work-around instructs dialysis facilities to enter occurrence code 
24 and the “date of receipt of denial by higher priority payer” on the claim form. An 
occurrence code 24 is intended for use when it is believed that another insurer covers a 
service but the insurer denies payment (CMS-104, Chapter 8, § 50.3) (CMS, 2013e). It 
allows the contractor to make a conditional payment, that is, a payment governed by MSP 
billing procedures. Both FCSO and the Puerto Rico dialysis facilities understand that the 
payments are actually primary, not conditional payments, as does CMS.
FCSO requires dialysis facilities and nephrologists to actually bill the 
beneficiary’s other insurer as if it were an MSP billing situation and assumes the insurer 
provides dialysis services as a cost-covered service as practiced on the U.S. mainland. 
Dialysis facilities and nephrologists do not submit the insurer denial with the claim; they 
are to retain it on file as documentation to confirm their entitlement to receive payment in 
case the claims are audited. This, unfortunately, can lead to the patient encountering 
additional out-of-pocket deductibles and additional bills related to the imposed insurer 
denial in this process. These bills are associated with the payer denying payment to the 
healthcare provider and then the healthcare provider may bill and pursue collection from 
the patient.
Although not intended by FCSO to create an onerous condition for dialysis 
facilities and nephrologists, the work-around procedure does so and, as noted above, also 
imposes an additional burden on patients. It requires dialysis facilities and nephrologists 
to expend resources to bill other insurers for services that they know the insurers do not 
cover so they can fill in a date for condition code 24 and file the record o f denial. The
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insurers have no incentive to cooperate with the work-around process and may not 
respond to the claim or respond very late. At best, dialysis facility and nephrologists 
billing for Medicare eligible services are substantially delayed. At worst, providers’ 
billing staff may lose track of some of the cases in the confusion resulting in a loss of 
revenue. If the standard Medicare claims system was revised so that it could recognize 
the claims at issue as payable by Medicare as primary payer, dialysis facilities and 
nephrologists would be entitled to bill immediately upon service and would be entitled to 
receive payment after the claims clear, as early as 14 days and no later than 29 days after 
claim submission. Claims not processed within that time would be payable with interest. 
Through no fault of their own, dialysis facilities and nephrologists do not receive these 
benefits.
In addition, some patients encounter partial coverage of care through two insurers 
(EGHP and Medicare) adding unnecessary co-payments and confusion around which 
insurer is the primary provider for other non-dialysis ESRD-related care. Confusion 
regarding cost-covered ESRD and non-ESRD services among the insurance agencies, 
patients, and the healthcare providers is a result of the common working file’s inability to 
process the claims of the newly diagnosed ESRD Medicare beneficiaries residing in 
Puerto Rico. This can lead to patients overpaying, or, even worse, unintended missed 
payments to an insurer, which could be forwarded to a collection agency leading to a 
poor credit rating or even legal proceedings. CMS educational materials for ESRD 
patients cover insurance issues related to the 30-month coordination period, but there are 
no materials or trainings for patients in Puerto Rico who must figure out on their own 
insurance issues based on a 90-day coordination period and any differences in
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apportionment of ESRD-related services.
Recommendations
The ideal solution is for the territory of Puerto Rico to adopt the 30-month ESRD 
coordination period. In lieu of that, one approach to a work-around at the provider level 
would be to revise how claims are processed in the common working file in a way that 
appropriately reduces the patient’s, dialysis facilities’, and nephrologists’ administrative 
burdens as follows. The common working file should incorporate an exception or waiver 
that allows the billing of ESRD beneficiaries who reside in Puerto Rico to be processed 
after 90 days, rather than 30 months. That common working file is a system that is 
usually simple for FCSO to manage, protects the Medicare trust fund against improper 
payments, and meets CMS’s timely and accurate payment objectives. When the Medicare 
beneficiary begins dialysis treatment, the provider would complete a questionnaire 
designed to determine whether Medicare is the primary or secondary payer. Puerto Rico 
beneficiaries typically have other insurance coverage, but not for dialysis 
services. According to the MSP manual, Chapter 3, § 10.1.5E (CMS, 2012c), “If the 
information obtained does not indicate EGHP coverage, the provider annotates the bill to 
that effect (e.g., EGHP coverage lapsed, benefits exhausted)”. That statement suggests 
that the Medicare claims system may actually have the flexibility to make primary 
payments for these claims without a major work-around, but merely adding the exception 
or waiver for Puerto Rico. If so, then the solution to dialysis facilities’ and nephrologists’ 
problem might already exist within standard billing procedures.
At a patient level, this would also help to address the additional insurance 
coverage gap. Many patients with a Medicare Prescription Drug Plan reach a point where
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their medication coverage runs out, known as the "donut hole". The traditional "donut 
hole" is due to a temporary limit on what a medication plan will cover. Patients in Puerto 
Rico not only face this issue, but also frequently face having to pay two deductibles for 
medications and other services due to having two insurers with unclear policies around 
attribution of coverage for costs as ESRD versus non-ESRD services and which insurer is 
responsible, creating a second “donut hole”.
In summary, if the adoption of the 30-month ESRD coordination period is not 
feasible and a work-around were still necessary, we recommend a process in which the 
provider would not bill the EGHP, but would still enter a date with condition code 24 that 
would be pre-approved by CMS to allow the claim to be processed. Alternatively, if a 
date is not required in the notation field, a standard comment appropriate to the situation 
could be entered. Thus, the claim could be submitted without delay and processed 
without error.
Dialysis facilities and nephrologists would still have to obtain and keep adequate 
documentation of the beneficiary’s lack of other insurance coverage for dialysis 
treatments during the ESRD coordination period. The documentation might consist of 
copies of the insurance contracts that show the benefits covered and any limitations. New 
copies of contracts could be obtained periodically to make sure there are no changes. If 
there are any further doubts, the insurer might be billed and issue an initial denial which 
could suffice throughout the remainder of the coordination period.
Effectively addressing the issue of a unique interpretation of the 30-month ESRD 
Coordination Period would be of significant benefit to both providers and patients. The 
proposed solutions represent potential strategies to more effectively address this issue.
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Again, a more complete solution would be to create a seamless and harmonized ESRD 
reimbursement system for the United States and all of its territories.
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Chapter Five 
Summary and Discussion
Two studies and a concept analysis were conducted addressing potential gaps in 
patient care management for chronic kidney disease. The reports included: Relationship 
between Age and Timely Placement o f  Vascular Access in Incident Patients on 
Hemodialysis, Relationship between Age and Pre-End Stage Renal Disease Care in 
Elderly Hemodialysis Patients, and Regional Variations in the Interpretation o f  the ESRD 
30-Month Coordination Period. The studies were partitioned into two areas of chronic 
kidney disease (CKD) research: the analysis of age-related differences in the receipt of a 
composite of recommended care to include nephrologist and dietician care and use of an 
arteriovenous fistula at first outpatient dialysis. The concept analysis addressed regional 
variations in the interpretation of the end stage renal disease (ESRD) 30-month 
coordination period. This chapter will provide an overview of the findings, the 
significance to research, nursing practice, and health policy, and a proposed plan for 
future research based on the studies’ findings and nursing implications.
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Findings and Statistical Analysis of Manuscripts
The first study Relationship Between Age and Timely Placement o f  Vascular 
Access in Incident Patients on Hemodialysis addressed the potential age related 
differences in use of a functioning arteriovenous fistula (AVF). The United States Renal 
Data System (USRDS), a national population based registry maintaining the largest 
dialysis data bank on almost all U.S. renal patients was used to extract dialysis data. The 
database houses and monitors characteristic profiles of renal-related disease groups, 
vulnerable populations, and communities with pre-end stage renal disease and kidney 
failure. For this study, the key variable was whether a patient used an AVF at the first 
outpatient hemodialysis therapy. Other study variables included demographic 
characteristics, employment status, health insurance coverage, and co-morbid conditions.
Four age groups were examined: <55 years of age, 55 to 66 years of age, 67 to 79 
years of age, and >80 years of age. Data were collected between the years 2005 through 
2010. The study included all new maintenance hemodialysis (MHD) patients treated with 
renal replacement therapy (RRT) in any of the 50 states or the District of Columbia who 
were 18 years or older at the time of initiation of dialysis and entered in the USRDS. U.S. 
territories were excluded. A total of 559,056 individuals were reviewed: 153,611 
(27.5%) were younger than 55 years of age, 154,126 (27.6%) were 55 to 66 years of age, 
168,044 (30%) were 67 to 79 years of age and 83,275 (14.9 %) were 80 years of age and 
older.
Logistic regression and descriptive analysis were used in the data analysis. 
Multiple analyses were conducted in adjusting for both unadjusted odds ratios with 
logistic regression, and then the odds ratios adjusted for other patient demographic data
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and characteristics. The study hypothesized that older patients were less likely to have a 
functioning AVF at the first dialysis treatment, however our findings showed the 
likelihood of using an AVF at first hemodialysis were lower for the youngest group and 
oldest groups (less than 55 years of age and 80 years and older).
In order to get a more comprehensive analysis of age related differences in the 
composite receipt o f pre-ESRD care; a second study was conducted. Unlike the first 
study, this study increased the number of key study variables (pre-ESRD care elements) 
and was designed on a broader scale. The second study was an expansion of the first.
Here we looked at a composite of three CMS recommended pre- ESRD care elements. In 
addition to the placement of a functioning AVF at the initial onset of incident 
hemodialysis care, the authors reviewed receipt of nephrologist care at least 12 months 
prior to receiving dialysis treatment and care by a dietician at any time prior to starting 
dialysis, resulting in a total of three pre-ESRD composite elements of care. Parallel to the 
first study, the USRDS database was used for data extraction. The same age groups were 
also used for comparative review. A sample of 412,291 individuals was examined. The 
study also hypothesized that older patients were less likely to receive the composite of 
CMS recommended pre-ESRD care elements than their younger counterparts.
The study used Poisson regression to evaluate findings. Poisson regression was 
used, which is most appropriate for frequency data, to compare four age categories (<55 
years of age, 55 to 66 years of age, 67 to 79 years of age, and > 80 years of age) 
expressed as ratios of the mean number of care elements received by respective age 
groups compared to that in the reference group (the 55-66 year group). The outcome 
variable was the composite of the three pre-ESRD care elements for MHD patients,
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measured as the total number of care elements received per patient (range: 0-3). Multiple 
analyses were conducted to evaluate for both adjusted and unadjusted ratios using patient 
characteristics and demographics, and other study variables. Consistent with the first 
study, the key findings revealed the receipt of recommended elements of care was lowest 
in the youngest (<55 years of age) and oldest groups (> 80 years o f age) when compared 
to the two groups in between. In addition to the above findings, the analysis revealed 
overall pre-ESRD care was extremely low. Less than 2% of the MHD population was 
reported to have received all three elements of recommended care. The actual receipt of 
care was 1.4%.
The concept analysis examined regional variations in the interpretation of the 
ESRD 30-month Coordination Period. Over an 8-month period, the authors conducted a 
search of regulatory documents as well as key stakeholder interviews regarding 
coordination of benefits for the ESRD patient. The findings revealed discordance in the 
interpretation and implementation of ESRD cost covered services between the Territory 
of Puerto Rico and the national ESRD insurance program. Many dialysis patients in 
Puerto Rico have employee group healthcare plans (EGHP), which cover dialysis 
services up to 90 days after the onset of ESRD (First Coast Services Options Inc.
[FCOS], 2014; Centers for Medicaid and Medicare Services [CMS], 2014). Based on the 
ESRD coordination period in Puerto Rico, after the 90-day period Medicare becomes the 
primary payer for dialysis treatments. This finding is contrary to the federal regulatory 
guidelines and practice in other states and territories where the ESRD Coordination 
Period is 30 months and not limited to 90 days after the onset of kidney failure (Code of 
Federal Regulations, 2011; CMS, 2013). It is important to note the national framework
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for processing ESRD audit and reimbursement claims processing is structured to 
coordinate ESRD claims processing on a 30-month coordination period, not 90 days.
The current system does not allow for a seamless payer transition for Medicare as 
the primary payer for ESRD patients residing in Puerto Rico after the 90-day 
coordination period. Consequently, this has created confusion among the payers, 
healthcare providers, and the patients in determining who are the primary and secondary 
payers. In addition, the extra work necessary to process the claims management and 
handing has resulted in an increase billing cost.
Research Questions and Hypothesis Findings
The conducted studies answered four questions central to the receipt of pre- 
ESRD composite care elements and policy variations on the 30-month Coordination 
Period policy for ESRD patients in the Territory of Puerto Rico. The first three questions 
examined the receipt of pre-ESRD composite care elements and were answered by the 
first two studies:
1. Is there a difference in rate of placement of an AVF prior to initiation of 
hemodialysis between persons aged > 67 years of age and those < 67 years of 
age?
2. Is there a difference in the rate of receipt of early nephrology care prior to 
initiation of hemodialysis between persons aged > 67 years of age and those < 67 
years of age?
3. Is there a difference in the rate of receipt of dietary care prior to initiation of 
hemodialysis between persons aged > 67 years of age and those < 67 years of 
age?
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As discussed earlier, our combined study findings revealed a low rate on the receipt of 
the three composite pre-ESRD care elements overall. These findings were consistent with 
the first study on AVF placement prior to the initiation of initial dialysis. In addition, the 
study hypothesized that persons aged > 67 years received a lower level of quality of care 
than younger persons < 67 years of age, however our findings indicated that both the 
younger and older age groups experienced a lower quality on the receipt of pre-ESRD 
care elements and not just the older age group as initially hypothesized.
The last question examined regional variances in the ESRD 30-month Coordination 
Period policy and was addressed in the policy analysis:
1. Is there a difference in the interpretation and implementation of the Coordination 
Period policy in Puerto Rico?
Our search on regional variance on the interpretation of the ESRD 30-month 
Coordination Period policy identified Puerto Rico as practicing a different ESRD 
coordination policy. While other territories and states work under a 30-month 
coordination period, Puerto Rico operates under a 90-day system. As discussed earlier, 
this variation in practice creates a complex processing system for ESRD claims resulting 
in higher billing costs and greater out-of-pocket expenses for patients, as well as 
confusion among the healthcare providers, payors and patients in determining order of 
payors.
Discussion
To our knowledge, these studies are the first of their kind examining age-related 
differences in the use of an AVF at the initial dialysis treatment along with the receipt of 
nephrology and dietician care prior to the start of dialysis care. Our findings are
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consistent with earlier research indicating older patients as having lowest rate of AVF 
placement at initial treatment along with other pre-ESRD care elements (Lilly et al.,
2012, Kim; Dessai, Chertow, & Winkelmayer, 2012). Work conducted by Gomes, 
Schmidt, & Wish (2013) discussed the clinical and pre-ESRD care challenges for those 
patients who may not be good candidates for AVF placement in addition to overall low 
rates of early CKD care in general. A thematic finding on pre-ESRD care studies is early 
nephrology care continues to be consistently low if not absent. Our findings were 
consistent with these studies.
The promotion of universal healthcare insurance coverage for pre-ESRD services 
across all age groups is needed to slow down the national burden of kidney disease. As 
noted in the regional variances of the ESRD coordination policy in Puerto Rico, 
confusion on cost covered services may lead to patients not seeking appropriate care for 
fear of high out-of-pocket expense. In addition, this confusion may also lead to healthcare 
providers not admitting new CKD patients for fear of non-payment. A re-examination of 
the national claims processing system is warranted based on Puerto Rico’s ESRD 
coordination policy. A more harmonized management of the overall billing and claims 
system may assist in simplifying the claims processing for Puerto Rico, the Medicare 
Administrative Contractor, and the national healthcare insurance program.
Implications
The summative findings of the three studies should be a reminder to all 
nephrology nurses as members of the pre-ESRD and ESRD multidisciplinary care team; 
nurses can make a difference at various levels of the healthcare spectrum. From policy 
development, research, and clinical practice, nurses have the opportunity to be at the
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forefront in the patient care and chronic disease management for the pre-ESRD and 
ESRD patient.
Significance to Research
Based on the study’s findings, immediate action is needed to implement a more 
comprehensive pre-ESRD patient care program and monitor its impact on the delivery of 
all three pre-ESRD care elements. Monitoring patient outcomes after initiation of renal 
replacement therapy may lead to improved early management of CKD and improved pre- 
ESRD and ESRD healthcare economics. Two key factors contributing to the increasing 
prevalence of CKD are an aging population and the leading CKD risk factors, diabetes 
and hypertension (Erdem, Prada, & Haffer 2013). Nurse researchers are strategically 
poised to assist in ESRD policy revision and innovative changes influencing the 
preventive and long-term management of chronic disease particularly with the aged 
ESRD patient. Collaborative partnerships with other professional healthcare agencies 
supporting kidney disease care platforms provide greater funding opportunities for renal 
research.
The first two studies described here specifically excluded data related to patients 
in the U.S. territories and protectorates. Similar research on the extent of pre-ESRD care 
and age-related discrepancies are warranted for those populations.
Significance to Nursing Practice
Currently national certification for the advanced nephrology nurse practitioner 
does not exist. The opportunity to develop a more expanded role for a nationally certified 
Advanced Nephrology Nurse Practitioner may help in the long-term care of both the pre- 
ESRD and ESRD patient. Gaps in the literature review support the need for new and
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innovative initiatives expanding the role for the renal nurse generalist, advanced nurse 
practitioner, and the renal patient care team (Davis & Zuber, 2013). The development of 
an advanced nephrology renal practitioner role may help to fill this void.
Significance for Health Policy
Clinical and/or psychosocial factors may underscore the less frequent receipt of 
pre-ESRD composite care in the older and younger kidney disease populations. Given 
that nurses are frequently providers of pre-ESRD education, a nurse-led quality 
improvement initiative grounded in person, health, environment, and nursing might help 
to better engage these two groups of high-risk patients, as well as the entire community of 
pre-ESRD patients (Key, 2008; McEwen & Wills, 2007). The nursing approach of 
assisting the individual with pre-ESRD to attain balance through holistic, patient-centered 
care and education may also assist to ensure that composite pre-ESRD goals are met 
(Key, 2008).
Quality improvement initiatives in geriatric ESRD care have been successfully 
implemented and may ultimately improve care for elderly patients with ESRD (Tamura, 
2009; Winkelmayer & Tamura, 2012). Our findings of reduced pre-ESRD care should 
help to clarify some of the opportunities for pre-dialysis decision-making and 
management in the older as well as younger MHD patients. Given our results, it is 
imperative that a more consistent approach to the provision of pre-ESRD care needs to be 
taken for this entire population.
At its most granular level, the nursing profession is patient-centric. This makes 
nurses unique in their ability to work one on one with both patient and family. More 
importantly, it positions them as strong patient advocates and clinicians. The confluence
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of these attributes places nurses at the leadership helm to assist in policy revision, 
development, and implementation.
Proposed Plan
The research assisted in further identifying gaps in the care of the dialysis patient 
population at a federal and territorial level, all of which influence renal disease 
management, nursing practice, and ultimately ESRD healthcare policy. In order to clearly 
understand next steps in the furtherance of the study, study limitations have been 
addressed. Study limitations include the cross sectional nature of the data that only 
allowed the team to assess relationships and not causal affects. In addition, prior reports 
have suggested the validity of the shared information from the CMS Medical Evidence 
Report and Medicare physician claims for pre-ESRD care is not clear, indicating a need 
for a more in-depth review of the data utilization and data management at a more 
germane level (Kim et al., 2012). The team plans to further investigate the utilization of 
other integrated healthcare and population census databases, which may help to improve 
the validity of the current database and provide opportunities for expansion into other 
research platforms. Adding a secondary database may strengthen future studies.
Finally, the research team has proposed that future studies are needed at the 
territorial level to obtain a better understanding of possible patient care gaps and potential 
economic effects at the federal and local level. Because the demand for dialysis care 
continues to grow, there is an urgent need for more studies in the renal area relating to 
policy and nursing practice. This study provided a platform for future territorial studies 
and in other areas with similar populations (e.g., rural settings).
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